Eli Lilly | LLY - Ricavi Di Vendita

Prezzo Delle Azioni
886.63
Cambio Giornaliero
8.39 0.96%
Mensile
-12.90%
Annuale
7.35%
Q1 Previsione
851.89




I Saldi Cambiamento Data
AbbVie USD 16.62B 840M 2025-12
Abbott USD 11.46B 90M 2025-12
ALKERMES USD 384.5M 9.7M 2025-12
Amgen USD 9.9B 340M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Baxter International USD 2.97B 130M 2025-12
Biogen USD 2.28B 250M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Coherus Biosciences USD 12.75M 1.18M 2025-12
Drreddys Laboratories INR 87.27B 1.82B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Glaxosmithkline GBP 11.46B 59.16M 2025-12
J&J USD 24.6B 610M 2025-12
Medtronic USD 9B 39M 2026-01
Merck USD 16.4B 880M 2025-12
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 13.86B 50M 2025-12
Novartis USD 13.86B 498M 2025-12
Novo Nordisk DKK 79.14B 4.16B 2025-12
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 283.44M 9.34M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
Sanofi EUR 12.2B 3.19B 2025-12
United Therapeutics USD 790.2M 9.3M 2025-12
Zoetis USD 2.4B 0 2025-12